2025 annual financial data
CytomX Therapeutics 2025 Operating margin
CytomX Therapeutics 2025 operating margin with verified reported values.
Direct answer
Operating margin was -29.35%.
Operating income was -22,364,000 USD and net income was -17,368,000 USD.
Operating cash flow was -75,587,000 USD.
Get free CytomX Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 76,201,000 USD
- Operating income
- -22,364,000 USD
- Net income
- -17,368,000 USD
- Operating cash flow
- -75,587,000 USD